I personally didn't see positives. In a couple of hints, what I got is:
- more shares to be sold in order to reach the 2.5 SE within the end of April through the ATM (if they are actually still trying to pursue that goal), considering that they only raised around 7.2 (if I do remember correctly) in the first quarter of 2018;
- triggering point of AGS-00 expected in the second half of the year (was it supposed to be in first half?), meaning that they most likely will need to raise more money anyway from today 'till year end, and thus (as it usually happens), most likely issue even more shares.
The first imminent triggering event I see right now is when the FDA will have a say on the protocol change at this point.
Obviously just my own opinion, please do your own DD.
